triiodothyronine has been researched along with Cardiac Complex, Premature in 6 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Excerpt | Relevance | Reference |
---|---|---|
"Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 7.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
" Since myocardial calcium uptake is increased in thyrotoxic rats, the efficacy of the calcium channel-blocking drug diltiazem in decreasing heart rate and the incidence of arrhythmias was evaluated in 11 hyperthyroid patients." | 7.67 | The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. ( Bentivoglio, M; Braverman, LE; Gardini, E; Guiducci, U; Minelli, R; Montermini, M; Robuschi, G; Roti, E; Roti, S; Salvi, M, 1988) |
"Amiodarone has a good antiarrhythmic effect administered either acutely or chronically." | 5.27 | [Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones]. ( Fazzini, PF; Gheri, RG; Marchi, F; Multinu, D; Paladini, S; Zambaldi, G, 1987) |
"Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 3.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
" Since myocardial calcium uptake is increased in thyrotoxic rats, the efficacy of the calcium channel-blocking drug diltiazem in decreasing heart rate and the incidence of arrhythmias was evaluated in 11 hyperthyroid patients." | 3.67 | The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. ( Bentivoglio, M; Braverman, LE; Gardini, E; Guiducci, U; Minelli, R; Montermini, M; Robuschi, G; Roti, E; Roti, S; Salvi, M, 1988) |
"Treatment with amiodarone resulted in a decrease in plasma T3 and free T3, an increase in plasma rT3, a marked diminution in the frequency of VPCs and a prolongation of the corrected QT interval (QTc)." | 1.27 | Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes. ( Biollaz, J; Goy, JJ; Lemarchand-Beraud, T; Magnenat, P; Nicod, P; Polikar, R; Schlapfer, J, 1986) |
"Amiodarone has a good antiarrhythmic effect administered either acutely or chronically." | 1.27 | [Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones]. ( Fazzini, PF; Gheri, RG; Marchi, F; Multinu, D; Paladini, S; Zambaldi, G, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iervasi, G | 1 |
Clerico, A | 1 |
Berti, S | 1 |
Pilo, A | 1 |
Biagini, A | 1 |
Bianchi, R | 1 |
Donato, L | 1 |
Valensise, H | 1 |
Civitella, C | 1 |
Garzetti, GG | 1 |
Romanini, C | 1 |
Polikar, R | 1 |
Goy, JJ | 1 |
Schlapfer, J | 1 |
Lemarchand-Beraud, T | 1 |
Biollaz, J | 1 |
Magnenat, P | 1 |
Nicod, P | 1 |
Gheri, RG | 1 |
Marchi, F | 1 |
Zambaldi, G | 1 |
Multinu, D | 1 |
Paladini, S | 1 |
Fazzini, PF | 1 |
Miyauchi, E | 1 |
Uchida, K | 1 |
Yamamoto, I | 1 |
Morimoto, S | 1 |
Maeda, T | 1 |
Miyamoto, M | 1 |
Takekoshi, N | 1 |
Murakami, E | 1 |
Roti, E | 1 |
Montermini, M | 1 |
Roti, S | 1 |
Gardini, E | 1 |
Robuschi, G | 1 |
Minelli, R | 1 |
Salvi, M | 1 |
Bentivoglio, M | 1 |
Guiducci, U | 1 |
Braverman, LE | 1 |
1 trial available for triiodothyronine and Cardiac Complex, Premature
Article | Year |
---|---|
Normalization of peripheral thyroid hormone metabolism induced by successful chronic amiodarone treatment in patients with ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Cardiac Complexes | 1996 |
5 other studies available for triiodothyronine and Cardiac Complex, Premature
Article | Year |
---|---|
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |
Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes.
Topics: Administration, Oral; Adult; Amiodarone; Cardiac Complexes, Premature; Electrocardiography; Female; | 1986 |
[Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Male; Middle Aged; T | 1987 |
[A case of chemical hyperthyroidism induced by antiarrhythmic agent amiodarone].
Topics: Amiodarone; Cardiac Complexes, Premature; Diabetes Complications; Humans; Hyperthyroidism; Male; Mid | 1988 |
The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients.
Topics: Adult; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Diltiazem; Drug Administration Schedule; | 1988 |